Bayer AG on Monday faced a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court.
from Reuters: Health https://ift.tt/2SqBBmC
No comments:
Post a Comment